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Abstract
Background: The gap junction protein, Connexin32 (Cx32), is expressed in various tissues including liver, exocrine
pancreas, gastrointestinal epithelium, and the glia of the central and peripheral nervous system. Gap junction-mediated
cell-cell communication and channel-independent processes of Cx32 contribute to the regulation of physiological and
cellular activities such as glial differentiation, survival, and proliferation; maintenance of the hepatic epithelium; and
axonal myelination. Mutations in Cx32 cause X-linked Charcot–Marie–Tooth disease (CMT1X), an inherited peripheral
neuropathy. Several CMT1X causing mutations are found in the cytoplasmic domains of Cx32, a region implicated in
the regulation of gap junction assembly, turnover and function. Here we investigate the roles of acetylation and
ubiquitination in the C-terminus on Cx32 protein function. Cx32 protein turnover, ubiquitination, and response to
deacetylase inhibitors were determined for wild-type and C-terminus lysine mutants using transiently transfected
Neuro2A (N2a) cells.
Results: We report here that Cx32 is acetylated in transfected N2a cells and that inhibition of the histone deacetylase,
HDAC6, results in an accumulation of Cx32. We identified five lysine acetylation targets in the C-terminus. Mutational
analysis demonstrates that these lysines are involved in the regulation of Cx32 ubiquitination and turnover. While these
lysines are not required for functional Cx32 mediated cell-cell communication, BrdU incorporation studies demonstrate
that their relative acetylation state plays a channel-independent role in Cx32-mediated control of cell proliferation.
Conclusion: Taken together these results highlight the role of post translational modifications and lysines in the
C-terminal tail of Cx32 in the fine-tuning of Cx32 protein stability and channel-independent functions.
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Background
Connexins are a family of 21 homologous integral mem-
brane proteins that form cell-cell channels, known as gap
junctions (GJ) [1–3]. GJ provide a low resistance pathway
for the diffusion of small molecules and ions between
coupled cells [4]. Recent data also suggest connexin in-
volvement in channel-independent processes including
cell growth, autophagosome formation, cell adhesion, cell
motility and cell migration [5–10]. The C-termini of
different connexins vary substantially in length and in
their capacity to mediate interactions with the cytoskel-
eton [11–13], and junctional complexes [12, 14]. The
C-terminal sequences of connexins have also been
implicated in voltage (reviewed in [15]), pH and chemical
[16–18], gating of different GJ channels. C-terminal
truncation of GJA1 (Connexin43; Cx43) does not alter
the ability to form functional gap junctions, but does
alter trafficking to the plasma membrane and gap junc-
tion plaque formation to indirectly reduces overall
GJ-mediated cell-cell communication [19–21]. Cytoplas-
mic domains in several connexins, including Cx43 and
GJB1 (Connexin32; Cx32), have also been implicated in
GJ-independent processes, such as regulation of cell
growth and gene expression [22–24].
The cytoplasmic domains of some connexins are sub-
ject to post translational modifications such as phos-
phorylation, ubiquitination, and acetylation, though
relatively little is known about how these modifications
impact function. To date, most investigations of con-
nexin post translational modifications have focused on
Cx43. Phosphorylation modulates Cx43-mediated GJ
communication through the modulation of channel
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closure [25], accretion in GJ plaques [25, 26], removal
from the plasma membrane, and subsequent protein turn-
over [27, 28]. Ubiquitinated Cx43 is targeted for degrad-
ation by the proteasomal [29, 30], endo-lysosomal [31],
and autophagosomal [32] pathways, depending on its sub-
cellular localization, specific ubiquitin moieties and modi-
fication sites. Acetylation of Cx43 has also been identified
as a negative regulator of plasma membrane localization
[33], although it is unclear if it influences Cx43 insertion
or degradation. Despite having been identified as a
phosphoprotein over 20 years ago [34], considerably less
is known about the abundance and functions of any
post-translational modifications of Cx32.
Cx32 is widely expressed in various tissues including
liver, exocrine pancreas, gastrointestinal epithelium, and
the glia of the central and peripheral nervous system.
Mutations in Cx32 cause X-linked Charcot–Marie–Tooth
disease (CMT1X), an inherited peripheral neuropathy [35,
36]. CMT1X associated mutations result in diverse alter-
ations in Cx32 expression and function, including defects
in trafficking and GJ formation and gating [35, 37–39].
More than 300 CMT1X mutations have been identified
covering most of the Cx32 gene (http://www.molgen.-
ua.ac.be/CMTMutations). CMT1X mutations in the
transmembrane and cytoplasmic loop regions prevent the
assembly of GJ in the plasma membrane CMT1X [40–42].
Mutations in the C-terminus of Cx32 result in functional
alterations but do not prevent GJ assembly [38].
The C-terminus of Cx32 has also been implicated in
processes such as Ca2+ regulated gap junctional gating
[43] and the modulation of cellular proliferation [44].
Post-translational modifications have been identified in
the C-terminus of Cx32, but their physiological signifi-
cance is poorly understood [45, 46]. In this study, we
focus on the role of post translational modifications of
C-terminal lysine residues in the modulation of Cx32
protein stability and function. We report here that Cx32
is acetylated and have identified five lysines in the
C-terminus as likely acetylation sites. Further, we dem-
onstrate that these lysines are involved in the regulation
of Cx32 protein stability, ubiquitination, and turnover.
Finally, while the acetylation state of these lysines are
not directly involved in modulating Cx32 GJ communi-
cation, we show their relative acetylation state plays a
role in Cx32-mediated control of channel-independent
cellular processes such as cell proliferation.
Methods
Cell lines
Cell lines were obtained from American Type Culture
Collection (ATCC, Manassas, VA). Cultures were main-
tained in DMEM supplemented with 10% FBS at 37 °C
and 5% CO2, at 100% humidity. Unless otherwise noted,
all experiments were performed using connexin-deficient
Neuro-2a (N2a) cells (ATCC #CCL-131). N2a cells were
used for subsequent experiments to maintain consistency
between electrophysiological, microscopic, and biochem-
ical analyses. HeLa cells (ATCC #CCL-2) were used in
preliminary experiments (Fig. 1a, b).
Plasmids
Rat Cx32 cDNA subcloned into pIRES2EGFP. To gener-
ate Myc/His-tagged constructs, rat Cx32 cDNA was
cloned into BamHI/ApaI sites of pcDNA3.1/Myc-His A.
The K➔R and K➔Q mutations were generated using
Genetailor site-directed mutagenesis kit, as per manufac-
turer’s recommendations (Invitrogen/Life Technologies)
and subcloned into relevant vectors. pIRES2EGFP-Cx32
was used for imaging, BrdU incorporation, and electro-
physiology experiments. pcDNA3.1-Cx32-Myc/His was
used in all other experiments to facilitate isolation of
Cx32 using the Myc and His epitope tags.
Western blotting
Total protein from N2a cells was harvested in PBS supple-
mented with 1% Triton-X 100. Samples were denatured
30 min at room temperature following addition of stand-
ard Laemmli SDS-PAGE loading buffer to limit aggregate
formation [47, 48]. Proteins were separated on 10% poly-
acrylamide denaturing gels and transferred to nitrocellu-
lose membranes. Blocking and antibody dilution was
carried out in PBS containing 2% BSA and 0.05% Tween.
Western blots were probed with mouse anti-Cx32 clone
7c6.7c (Elliot Hertzberg) 1:1000, rabbit anti-Myc tag
(AbCam) 1:2000, rabbit anti-acetylated proteins (Ack, Cell
Signaling Technologies) 1:1000, mouse anti-ubiquitinated
proteins clone P4G7 (Covance)1:200, and mouse
anti-β-tubulin clone 3F3-G2 at 1:2000. Goat anti-rabbit
IRdye800 and goat anti-mouse IRdye700 secondary anti-
bodies (LiCor) were used for detection and digital images
were obtained with the Odyssey imaging system (LiCor).
Western blots were also analyzed using GelQuant.NET soft-
ware (http://biochemlabsolutions.com/GelQuantNET.html),
normalizing to actin or β-tubulin signal, where appropri-
ate. Fold change was calculated relative to untreated WT
signals for each probe.
Drugs and other chemicals
TubastatinA (TubA, Chemie Tek) and Trichostatin A
(TSA, Sigma) were dissolved in DMSO (1 mM and
20 μM, respectively) prior to further dilution in medium.
All other chemicals were obtained from Sigma Aldrich,
unless otherwise indicated. Cells were treated with
20 μM TubA for 3 h, unless otherwise indicated.
Transfections
N2a cells were transiently transfected using Lipofecta-
mine LTX (Invitrogen/Life Technologies) according to





Fig. 1 HDAC6 inhibition reduces turnover and increases acetylation of Cx32. a TSA and (b) TubA increase expression level of Cx32. Western blots
of N2a cell lysates treated with the TSA (concentrations as indicated) (a) or 20 μM TubA for 6 h (b) were probed with anti-Cx32, actin (a) or tubulin (b)
was used as a loading control. c TubA treatment decreases turnover of Cx32 (bottom panel) compared to untreated samples (top panel). Protein
turnover of 35-S-Cx32 was determined by phosphorimaging at 0, 1, 2, 4 h post-chase (shown). Blots were subsequently probed with anti-Myc as a
loading control. d Relative levels of 35-S-Cx32 remaining after 1.5 h post-chase (in subsequent experiments) was quantified by densitometry of
phosphorimages, normalized to Myc, and used to calculate half-life, as described (see Methods). (N = 4 independent experiments; student’s
T-test* p< 0.05 as compared to DMSO control). e TubA increases expression levels of total Cx32 and acetylated Cx32. Cx32 immunoprecipitates of N2a cell
lysates expressing Cx32-Myc/6xHis treated with TubA or vehicle alone were processed for Western blots analysis and probed with Cx32 and AcK antibodies
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the manufacturer’s instructions. Antibiotic-free media
was used for transfection reactions and all subsequent
culture steps. Transfected cells were re-seeded on to
glass coverslips at 12–16 h post-transfection for electro-
physiology and immunofluorescence experiments.
Immunofluorescence and BrdU incorporation
Transfected cells were grown overnight after seeding on
to glass coverslips, treated as described, and fixed 15-min
at room temperature with Histochoice (Amresco). Cover-
slips were washed with PBS supplemented with 0.05%
Tween. Blocking and antibody dilutions were carried out
in PBS supplemented with 0.05% Tween and 2% BSA.
Cx32 was probed with mouse anti-Cx32 clone 7C6.6
(1:1200). Signal was detected with Alexa-Fluor-conjugated
secondary antibodies (Molecular Probes) and the cover-
slips were mounted using ProLong Gold plus DAPI (Mo-
lecular Probes) or Fluoromount (Invitrogen) with DAPI.
For proliferation studies, cultures were treated with
BrdU (10 μM, Molecular Probes) overnight and fixed with
Histochoice as described. Immunofluorescent detection of
Cx32 preceded denaturation and immunolabeling for
BrdU. Following immunolabeling for Cx32, samples were
denatured 30 min with 2 N HCl in 0.1% Triton-X-100,
neutralized with 0.2 M Borate buffer, pH 9.0 and washed
with PBS. The samples were then processed for BrdU
incorporation using monoclonal anti-BrdU (LabVision/
ThermoFisher;1:150) immunofluorescence.
Imaging
A Zeiss LSM 700 confocal microscope system was used to
obtain Z-stacks at 63× magnification. All images were ob-
tained with a pinhole size of 1 airy unit. Laser power, filter
settings, beam splitter, and scan mode were the same for
all images. Confocal imaging was used to obtain Z-stacks
of 0.29um slices (63X). Images shown are maximum in-
tensity projections of 5 slices that were most in focus at
points of cell-cell contact. Integrated fluorescence values
were obtained from background subtracted images using
the Cell Scoring and Multi-Wavelength Cell Scoring ap-
plets in Metamorph 7 image analysis software (Molecular
Devices). Thresholds were determined using negative con-
trol images and cellular integrated fluorescence consti-
tuted less than 10% of positively scored cells.
Cell lysate preparation for immunoprecipitation and Co2+
purification
Cells were scraped into PBS and collected by low speed
centrifugation. The cell pellets were lysed in PBS supple-
mented with 1% Triton-X 100 and protease inhibitors
(LB). 20% SDS was added to a final concentration of
1.2% and incubated on ice 30 min to solubilize gap junc-
tions [49]. For immunoprecipitation, sufficient LB was
added to dilute SDS to a final concentration of 0.4%.
The lysate was passed through a 26.5-gauge needle and
centrifuged to remove debris. For His-tagged Cx32,
Hispur-Co2+ coated agarose beads (Pierce) were added
to the cleared supernatant and incubated as per manu-
facturer’s suggestions. His-tagged Cx32 was eluted with
lysis buffer containing 300 mM imidazole, as per manu-
facturer’s suggestions. Where noted, samples were
immunoprecipitated using an affinity purified rabbit
polyclonal to Cx32 raised to C-terminal peptides (E.
Hertzberg) with Protein G-agarose beads (Pierce/Ther-
moFisher) and eluted as per manufacturer’s suggestions.
35-S met/Cys pulse-chase assay
Cells were transfected 48 h prior to experiments. Each
experimental sample consisted of confluent 10 cm plate
of transfected cells. For +/− TubA experiments, cells
were pretreated with 20 μM TubA or DMSO for 16 h
prior to Met/Cys pulse. Cells were rinsed with 3 × 4 ml
PBS and then starved in DMEM lacking serum, methio-
nine, and cysteine for 1 h. The 35-S-Met/Cys pulse was
carried out for 20 min (+/− TubA experiments) or five
minutes (WT versus 5R or 5Q).
Radioactive pulse media containing 50 mCi/ml of
35-S-Met/Cys (Expre35-S35-S labeling mix, Perkin Elmer),
10% FBS, and Met/Cys-free DMEM was used for each
sample. After radioactive pulse, each plate was washed
thrice with PBS and chased with complete DMEM with
an additional 20 mMMet/Cys for indicated times.
Cell lysates were prepared as described above and
Cx32-Myc/His was isolated with Co2 + −agarose resin. Co2
+ purified Cx32 was analyzed by western blotting.
35-S-labeled Cx32 was detected by exposing the blots over-
night to a storage phosphor and then imaging with a Storm
Phosphorimager (GE Life Sciences). Then the blots were
probed with antibodies against the Myc tag as a loading
control. 35-S-Cx32 and Cx32-Myc/His bands were quanti-
fied using image-J and normalized; that is, 35-S-Cx32
values were obtained for each sample by dividing
35-S-Cx32 band intensity by Cx32-Myc/His band intensity.
Cell surface biotinylation
Biotinylation experiments were carried out 48 h
post-transfection, following a 3 h treatment with TubA or
DMSO. Confluent 60 mm plates of transfected cells were
used for each experimental sample. Cell surface proteins
were labeled with EZ-Link Sulfo-NHS-SS-Biotin (0.5 mg/ml;
Thermo Scientific) for 30 min on ice. After biotinylation,
cells were rinsed and blocked with PBS supplemented with
100 mM Glycine. Samples were lysed immediately or chased
for 1.5 h with complete medium in the presence of TubA or
DMSO, as indicated.
Cells were harvested and lysed in PBS supplemented
with 1% Triton-X 100 and protease inhibitors, as de-
scribed for immunoprecipitation. Aliquots of total
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protein were obtained prior to isolation of biotinylated
proteins. Biotinylated proteins were isolated by binding to
neutravidin-agarose beads (Thermo Scientific) and then
eluted with SDS-PAGE sample buffer and subjected to
western blotting along with total protein samples. Total
protein samples were diluted accordingly to permit detec-
tion of both the eluate and total fractions using the same
blotting conditions. Biotinylated and total Cx32 was de-
tected by probing with an antibody against Myc-tag.
Electrophysiology
Conductance measurements were made by pulsing from
Vj = 0 to +/− 40 mV. After recording from cell pairs
Cytoplasmic bridges were excluded by demonstrating the
sensitivity of the recorded junctional conductance to appli-
cation of bath solution containing octanol. Values for differ-
ent pairing configurations were compared using the
Kruskal-Wallis test with Dunn’s multiple comparison
post-test. For determination of steady-state junctional
conductance-junctional voltage (Gj-Vj) relations, cells were
held between each pulse at Vj = 0 for 22.5 s, and cell 1 was
pulsed in 20 mV increments from − 100 to + 100 mV for
12.5 s. Any resulting change in current in cell 2, the ap-
posed cell, is attributable to junctional current. Currents
are displayed with positive up for both cells; thus, a positive
Vj step in cell 1 causes a downward deflection in cell 2. For
WT and mutants with measurable conductance at
Vj = 0 mV, voltage pulses were preceded by a short
(~ 200 mS) pulse to − 20 mV for normalization. Data were
collected as described. Steady-state (t =∞) conductances
were determined by fitting each current trace to a sum of
exponentials. Dividing the current at t =∞ by the applied
voltage gives the steady-state junctional conductance.
For determination of Boltzmann parameters,
steady-state plots were fit to the product of two Boltz-
mann distributions of the form:
Gss Vð Þ ¼ fGmin þð Þ þ Gmax þð Þ Gmin þð Þð Þ=
ð1þ e A þð Þ V  V0 þð Þð Þ½ g 
Gmin −ð Þ  Gmin −ð ÞÞ= 1þ e A −ð Þ V−V0 −ð Þð Þ½ ð Þf g
where Gss is the steady-state junctional conductance nor-
malized to Vj = 0, Gmax is the maximal normalized conduct-
ance, and Gmin is the normalized residual conductance,
which in macroscopic recordings is approached as the abso-
lute value of Vj is increased, V0 is the voltage at which the
conductance is 1/2 of the difference between Gmin and
Gmax and roughly corresponds to the voltage at which a
single connexin hemichannel has an open probability of
50%, and A is a parameter which reflects the slope of the
Gj-Vj plot and is a measure of voltage sensitivity. A = nq/kT
where n is the effective gating charge and q, k and T have
their usual meanings. The (+) and (−) designations indicate
that the parameters are fitted to the positive or negative
limbs of the Gj-Vj relation. The model makes two as-
sumptions that may not always be met for connexin
gating: 1.The gating process has two states, 1where the
energy difference between the states is proportional to
the applied voltage, and 2: The steady state Gj-Vj arises
from the gating of two independent apposed hemichan-
nels. Whether or not assumptions 1 and 2 are met, the
parameters generated provide a useful basis for com-
parison among channels produced by various pairing
configurations of mutant and WT connexins. Homoty-
pic pairs of Cx32WT- IRES-EGFP served as a positive
control and pairs of empty vector expressing cells
served as negative controls for homotypic pairing of
mutants. For heterotypic cell pair controls, an additional
“heterotypic” pairing of Cx32WT-IRES-EGFP with
Cx32WT-IRES- DSRed expressing cells was performed.
Pipette solution: 145 mM CsCl, 5 mM EGTA, 1.4 mM
CaCl2, 5.0 mM HEPES pH 7.2; Bath solution: 150 mM
NaCl, 4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM
Dextrose, 2 mM Pyruvate, 5 mM HEPES; pH 7.4.
Results
HDAC6 inhibition causes Cx32 protein accumulation
Post-translational acetylation can regulate protein turn-
over [50–53]. Histone deacetylases (HDACs) form a func-
tional class of cellular enzymes that remove acetyl groups
from modified lysines of histones and other proteins. We
chose inhibitors of HDACs as tools to investigate whether
Cx32 is post-translationally acetylated and if this alters
levels or stability of accumulated Cx32. Treatment of
Cx32 transfected HeLa cells with a broad spectrum
HDAC inhibitor, Trichostatin A (TSA), resulted in a
2.5-fold accumulation of Cx32 protein relative to un-
treated transfected cells (Fig. 1a). Histone Deacetylase 6
(HDAC6) is a cytoplasmic protein [54, 55] with several
known non-histone cytoplasmic substrates [56–58]. Un-
like other HDACs inhibited by TSA, HDAC6 inhibition
does not alter histone acetylation. We therefore hypothe-
sized that specific inhibition of HDAC6 would also result
in the accumulation of acetylated Cx32 protein, independ-
ent of transcriptional perturbations that can result from
broad spectrum TSA HDAC inhibition.
Treatment of transfected cells with the HDAC6-
specific inhibitor, TubastatinA (TubA; Fig. 1b) increased
the relative levels of Cx32 protein levels (3.7-fold±0.35
SEM, N = 5 independent experiments) compared to ve-
hicle treated cells. To determine whether HDAC6 inhib-
ition altered the half-life of Cx32, we performed 35-S
pulse-chase experiments, comparing turnover of Cx32 in
transfected cells treated with TubA to those treated with
vehicle alone. 35-S labeled Cx32 detected by phosphori-
maging was compared to total Cx32; Fig. 1c shows that
half-life was increased by TubA treatment compared to
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untreated samples. To control for increased levels of Cx32
following TubA treatment, blots were normalized to total
Cx32 for each treatment condition and reported as the
percentage 35-S Cx32 remaining at t = 1.5 h. HDAC6 in-
hibition approximately doubled the amount of 35-S-Cx32
remaining at 1.5 h (from 40% in vehicle treated controls
to 79% in TubA treated samples; Fig. 1d.). These results
suggest that increased accumulation of Cx32 in response
to HDAC6 inhibition results from stabilization of Cx32
protein rather than increased Cx32 transcription.
To confirm TubA activity, relative levels of Cx32
acetylation were determined using anti-acetylated lysine
antibody (AcK) to probe western blots of immunopreci-
pitated Cx32. This revealed increased acetylation of
Cx32 in concert with increases Cx32 protein in response
to TubA inhibition of HDAC6 (Fig. 1e).
We next asked whether stabilization of Cx32 in
Cx32-transfected cells resulted from reduced turnover of
cell-surface-localized Cx32 or increased presence in
other subcellular compartments. Cell-surface biotinyl-
ation experiments were carried out to determine if acet-
ylated Cx32 was accumulating preferentially at the cell
surface. This was assessed by comparing the cell
surface-labeled Cx32 in cells that had either been treated
with TubA or DMSO immediately after labeling and
after a1.5 h chase period.
Cx32-transfected cells were pre-treated with TubA or
DMSO for three hours and subsequently labeled with
Sulfo-NHS-SS-Biotin, a membrane impermeant biotin de-
rivative, to tag cell surface proteins. Following cell-surface
biotinylation, the cells were either lysed immediately (T0)
or incubated an additional 1.5 h (T1.5) in the presence of
TubA- or DMSO-containing medium to assess the total
amount of biotinylated Cx32 from the cell surface labeled
pool remaining at T1.5 following quenching. Biotinylated
and total Cx32 were determined following western blot.
Biotinylated Cx32 levels were normalized to total immu-
noprecipitated Cx32-Myc and expressed as the ratio bioti-
nylated:total Cx32 (Fig. 2a). Vehicle-treated controls
showed a higher ratio of biotinylated Cx32 to total Cx32
(2.0 ± 0.24 SEM, N = 3 independent experiments) at T0,
compared to TubA-treated cells (0.76 ± 0.09 SEM, N = 3
independent experiments) (Fig. 2b). Treatment with TubA
resulted in elevated levels of biotinylated-Cx32 relative to
total Cx32 at 1.5 h after cell-surface labeling; suggesting
that inhibition of HDAC6 which increases relative levels
of acetylated Cx32 also stabilizes the membrane-
associated (biotinylated) pool of Cx32. At 1.5 h
post-biotinylation, 82% (±12% SEM, N = 3 independent
experiments) of biotinylated Cx32 relative to total Cx32
remained in TubA samples while only 48% (±5.5% SEM,
N = 3 independent experiments) of biotinylated Cx32
remained in vehicle-treated samples (Fig. 2c); further
supporting the conclusion that Cx32 levels are
stabilized or enhanced by TubA inhibition of HDAC6
and that reduced acetylated-Cx32 at baseline in the ab-
sence of TubA (Fig. 1e) leads to loss of biotinylated
Cx32 following quenching. Immunofluorescent staining
and confocal imaging confirmed these results (Fig. 2d,
Additional file 1: Figure S2, Additional file 2: Figure S3,
Additional file 3: Figure S4 and Additional file 4: Figure
S5). Cx32 staining in both cytoplasmic and cell surface
pools was visibly increased after 6 h of TubA treatment
(Fig. 2d, Additional file 1: Figure S2, Additional file 2:
Figure S3, Additional file 3: Figure S4 and Add-
itional file 4: Figure S5). Taken together, these results
suggest that inhibition of HDAC6 decreases degrad-
ation and stabilizes Cx32, leading to its accumulation
in both cell surface and cytoplasmic cell compartments.
C-terminal lysines are implicated in HDAC6 inhibitor response
Connexins contain three cytoplasmic domains (N-terminus,
cytoplasmic loop, and C-terminus) that provide potential
sites for regulation of protein turnover by post-
translational modification. Nine lysines were identified in
the cytoplasmic domains of Cx32. To determine if these
residues were targets for acetylation and enhanced accu-
mulation of Cx32, point mutations for each cytoplasmic
lysine were generated and tested for resistance to the ef-
fects of HDAC6 inhibition. Mutation of lysine to arginine
(K➔R) conserves the positive charge from lysine, but
blocks acetylation [50, 59]. By contrast, lysine to glutamine
mutations (K➔Q) are often mimetic of acetylation [59].
K➔R mutants in the cytoplasmic loop showed no differ-
ences compared to WT at baseline or following TubA
(Fig. 3a, top), indicating the acetylation state of residues in
this domain were not involved in mediating levels of Cx32
protein. Individual K➔R mutation of C-terminal lysines,
however, reduced the TubA-stimulated accumulation of
Cx32 protein, as compared to WT Cx32 (Fig. 3a bottom,
3B). To determine whether alteration of all five C-terminal
lysines would further impact Cx32 accumulation, con-
structs in which all five C-terminal lysines were converted
to arginine (5R) or glutamine (5Q) were tested for TubA
induced accumulation of Cx32. Figure 3b shows that 5R
Cx32 is resistant to TubA treatment, whereas HDAC6 in-
hibition in 5Q Cx32 results in increased levels of Cx32.
To determine whether modification of several
C-terminal lysines was necessary for the effect, constructs
in which all five C-terminal lysines were converted to ar-
ginine (5R) or glutamine (5Q) and probed for changes in
acetylation. The double K231 + K260➔R mutant failed to
detectably alter levels of Cx32 acetylation (Additional file 5:
Figure S1), supporting the modification of all five
C-terminal lysines. Cx32 was immunoprecipitated from
transfected cells and acetylated Cx32 was detected by
western blotting. We found that 5R Cx32 was still acety-
lated, but that this acetylation did not increase in response
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to TubA treatment (0.86 ± 0.15 SEM, 5R vs WT; N = 4 in-
dependent experiments) (Fig. 3c). This suggests that the
observed increase in Cx32 acetylation and accumulation
of Cx32 protein in response to HDAC6 inhibition was
dependent upon C-terminal lysines. The relative acetyl-
ation level of 5Q Cx32 was 3.86-fold lower than WT
(0.26 ± 0.15 SEM, 5Q vs WT; N = 4 independent experi-
ments) but increased in response to HDAC6 inhibition
(1.0 ± 0.28 SEM, 5Q vs WT; N = 4 independent experi-
ments) (Fig. 3c). This is agreement with our finding that
accumulation of 5Q Cx32 protein still occurred in re-
sponse to HDAC6 inhibition (Fig. 3b). These results sug-
gest that a subset of the C-terminal lysines could be
acetylation sites, but other potential acetylation sites are
available with HDAC6 inhibition under these experimen-
tal conditions.
To determine whether 5R and 5Q modification of
C-terminal lysines altered acetylation, cells transfected
with 5R and 5Q constructs were treated with TubA and
probed for changes in Cx32 acetylation compared to
WT. The relative acetylation level of the 5Q Cx32
acetylation mimetic was 3.86-fold lower than WT (0.26
± 0.15 SEM, 5Q vs WT; N = 4 independent experi-
ments) but increased in response to HDAC6 inhibition
(1.0 ± 0.28 SEM, 5Q vs WT; N = 4 independent experi-
ments) (Fig. 3c) in agreement with our finding that ac-
cumulation of 5Q Cx32 protein occurred in response to
HDAC6 inhibition (Fig. 3b). The 5R Cx32 block mu-
tant, however, was also acetylated, but this acetylation
did not respond to HDAC6 inhibition with TubA
(0.86 ± 0.15 SEM, 5R vs WT; N = 4 independent ex-
periments) (Fig. 3c); suggesting that, under the experi-
mental conditions described, other acetylation sites
may become available with inhibition of HDAC6.
Taken together, these results support the involvement
of the C-terminal residues in the observed increase in





Fig. 2 HDAC6 inhibition results in the accumulation of both cytoplasmic and cell surface Cx32. a TubA treatment stabilizes Cx32 levels as determined
by increases in levels of biotinylated Cx32 at 1.5 h after labeling. N2a cell were transfected with Cx32-Myc/6xHis and treated with TubA or vehicle for
3 h prior to biotinylation of cell surface proteins. Following cell surface biotinylation, cultures were harvested and processed for total lysate (top) and
biotinylated Cx32-Myc/6xHis (bottom) by Western blot, as described in Methods. b Densitometric quantification of Western blots shows a significant
reduction in biotinylated Cx32/total Cx32 at T0 in TubA-treated samples as compared to vehicle-treated cells. c A significant increase in biotinylated
Cx32/total Cx32 remained at T1.5 compared to vehicle-treated (N = 3 independent experiments, Student’s T-test *p < 0.05). d Immunostaining and
confocal microscopy cell surface labeling of Cx32 confirmed TubA treatment increases Cx32 accumulation in cell surface and cytoplasmic compartments
(see also Additional file 5: Fig. S1). Images shown were obtained at 63X magnification and scale bars = 25 μm. Arrows indicate points of cell-cell contact
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C-terminal lysines regulate Cx32 ubiquitination and turnover
Ubiquitination of lysines impacts protein turnover and can
be regulated by lysine acetylation [60]. We hypothesized
that hyper-acetylation of putative acetylation sites could re-
duce the availability of Cx32 ubiquitination sites, thereby
reducing turnover of the protein. Levels of ubiquitination
in the 5Q Cx32 mimetic was significantly lower relative to
WT (15% +/− 2% SEM, N = 3 independent experiments)
(Figs. 4a, b). Ubiquitination of 5R Cx32 block was reduced
to 47% (+/− 15% SEM, N = 3 independent experiments) of
the WT level, consistent with observed baseline acetylation
levels (Fig. 4a, b). Given that a poly-ubiquitinated and mul-
tiple mono-ubiquitinated protein present similarly by SDS
PAGE and Western blot, the possibility of a reduction in
poly-ubiquination of 5R must be considered along with de-
creases in mono-ubiquination. 35-S pulse-chase experi-
ments showed that replacement of C-terminal lysines with
glutamine (5Q), in order to mimic constitutive acetylation,
slowed down Cx32 by turnover to an even greater extent
than the 5R acetylation block mutation (Fig. 5a, b.), despite
the reduction in turnover with 5R compared to WT (Fig.
5a, b). Taken together, these results confirm our initial ob-
servations with HDAC6 inhibition of WT Cx32 and pro-
vide further support for that modulation of C-terminal





Fig. 3 C-terminal lysines are required for HDAC6 inhibitor-induced accumulation of Cx32. a Mutation of C-terminal (bottom), but not cytoplasmic
loop (top), lysines prevented Cx32 accumulation in response to TubA treatment. N2a cells transfected with either Cx32-Myc/6xHis or site-specific
Cx32-Myc/6xHis K➔R acetylation-deficient mutants were treated with DMSO or TubA and processed for Western blot. Blots were probed for Myc-tag
to detect Cx32, with beta-tubulin as a loading control. (Note that vertical lines between samples in figure indicate use of sister blots, run simultaneously.)
(b) N2a cells were transfected with either Cx32-Myc/6xHis (WT), acetylation-deficient multi-site lysine to arginine mutant of all five cytoplasmic C-terminal
lysines (5R), or acetylation-mimetic multi-site lysine to glutamine mutant of the five C-terminal lysines (5Q). WT, 5R, 5Q expressing cultures were treated
with TubA or vehicle and assessed for Cx32 expression as in (a). c WT, 5R, 5Q expressing cultures were treated with TubA or vehicle and assessed for
acetylation with anti-AcK. Cultures were immunoprecipitated with affinity purified rabbit-anti-Cx32 (E. Hertzberg) and probed with mouse monoclonal
anti-Cx32 (7C6.7C; E. Hertzberg) or anti-AcK. Basal levels of acetylation were lower, as predicted, in untreated 5R and increased in 5Q relative to total
Cx32. Treatment with TubA increased WT and 5Q acetylation, while 5R levels remained largely unchanged
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C-terminal lysines are dispensable for GJ function
To determine if the 5R and 5Q mutants altered formation
of functional Cx32 GJ, we performed dual whole cell re-
cordings to assess trans-junctional conductance and volt-
age gating. Dual whole cell recordings of trans-junctional
conductance indicated that 5R and 5Q Cx32 formed func-
tional GJ (Fig. 6a, b). Both Cx32 mutants generated
trans-junctional voltages that were comparable to WT
Cx32, indicating that cells expressing all three constructs
were well coupled. We also evaluated the relationship be-
tween applied voltage and trans-junctional conductance
to determine if the voltage gating of the either mutant dif-
fered from that of WT Cx32. The voltage gating of 5R and
5Q resembled WT Cx32, indicating that the mutations
did not alter the structure of cytoplasmic motifs involved
in voltage gating (Fig. 6c). This provided further evidence
that neither the C-terminal lysines of Cx32, nor their
post-translational modification, are required for normal
GJ function. This is not surprising considering that the
truncation of Cx32 at R220, has only a small effect on the
steady state conductance- voltage relation.
Cx32 acetylation regulates cellular proliferation
Cytoplasmic domains of connexins have been implicated
in a variety of physiological processes, such as the regula-
tion of cellular proliferation, independent of their role in
cell-cell communication [44, 61–63]. We hypothesized
that acetylation of Cx32 could impact its role as a regula-
tor of cellular proliferation. BrdU incorporation assays
compared the fraction of proliferating cells found in cul-
tures expressing WT, 5R, and 5Q Cx32. Expression of 5R
Cx32 significantly reduced BrdU incorporation and
immunolabeling (Fig. 7a, c) compared to WT and 5Q
Cx32. This result suggests that blockade of Cx32
C-terminal acetylation can act as a modulator of
channel-independent cellular processes, including cellular
A
B
Fig. 4 C-terminal lysines modulate Cx32 ubiquitination. a Ubiquitination levels of 5R, and 5Q Cx32, relative to WT, was assessed by probing Western
blots of Co2+ affinity-purified Cx32-Myc/6xHis with antibodies against pan-ubiquitin and Myc-tag. Note that monoubiquitin has a molecular mass of
8.5 kDa and thus the bands shown here could represent polyubiquitinated and multi-mono-ubiquitinated Cx32. b Densitometric quantification of
Ub-Cx32 as a percentage of WT Ub-Cx32 is shown here. Relative levels of Ub-Cx32 were 47% and 15% for 5R and 5Q, respectively, versus WT (N = 3
experiments, Student’s T-test: * p < 0.05)
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proliferation. To determine whether expression of WT,
5R, or 5Q Cx32 interfered with N2a cell survival, the per-
centage of Cx32 expressing cells versus total cells in each
group was determined. We detected no difference be-
tween the percentage of cells expressing either mutant
versus WT (Fig. 7b, c), suggesting that the reduction in
BrdU incorporation observed in the 5R group was likely
due to decreased proliferation rate rather than to toxicity
of the mutant protein.
Discussion
The data presented here address the role of C-terminal
lysines and their post-translational modifications as reg-
ulators of Cx32 function. Our results demonstrate that
acetylation of C-terminal lysines modulates levels and
turnover of Cx32 protein in the cell. Changes in acetyl-
ation of these C-terminal lysines, in turn, alters ubiquiti-
nation of Cx32, such that levels of ubiquitination
respond to occupancy or modification of these identified
acetylation sites. Acetylation reduced turnover and in-
creased accumulation of Cx32 protein throughout the
cell. The acetylation state of C-terminal lysines did not
affect functional GJ channel activity.
We utilized deacetylase inhibitors to promote the accu-
mulation of acetylated Cx32 and determined that HDAC6
a regulator of Cx32 acetylation. Specific inhibition of
HDAC6 stabilized Cx32 protein, causing it to accumulate
throughout the cell, while increasing its acetylation and
decreasing its ubiquitination. These results recapitulated
our initial results with the broad type I and II deacetylase
inhibitor, TSA. Our analysis of cytoplasmic lysine mutants
of Cx32 revealed that C-terminal lysines are involved in
the Cx32 accumulation which results from HDAC6 inhib-
ition. Previous studies have shown that C-terminal trunca-
tion mutations of Cx32 retain the capacity to form
functional GJ, with a resultant level of cell-cell coupling
that is inversely proportional to the number of amino
acids that were truncated [64, 65]. Furthermore, much of
the truncated Cx32 accumulates in the cytoplasm, impli-
cating the C- terminus in the regulation of GJ assembly
and/or disassembly [66]. We found that the C-terminal
K➔R and K➔Q mutations did not prevent Cx32 from
reaching the cell surface (Additional file 1: Figure S2 and
Additional file 2: Figure S3) but may alter the levels of
plasma membrane Cx32 maintained over time. The re-
sults presented provide further support for a model of GJ
assembly that is regulated by the C-termini of connexins.
Specifically, post-translational modifications of C-terminal
lysines modulate the amount of Cx32 maintained at the
cell surface. This cell surface pool of Cx32 may be incor-
porated into GJ or may exist as hemichannels, either of
which could regulate downstream physiological processes.
Our interpretation of the single residue K➔R muta-
tions shown in Fig. 3a. is limited by the possibility that
A
B
Fig. 5 C-terminal lysines modulate Cx32 turnover. a Cells expressing Myc/6xHis tagged WTCx32, 5RCx32, or 5QCx32 were pulsed with 35-S-Met/Cys
for 5 min and lysed (0) or chased 1.5 h in complete medium (1.5). Cx32-Myc/His was isolated by affinity purification and processed for Western
blotting. 35S-Met/Cys incorporation into newly synthesized Cx32-Myc/His was detected by phosphorimaging and the blots were subsequently probed
with anti-Myc antibody to detect Cx32-Myc/His. b Densitometric quantification of 35-S Cx32 remaining after 1.5 h. 35-S was quantified and normalized
to total Cx32-Myc amount (*p < 0.05, Student’s T-test, N = 3)
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modifications at a given residue result in alterations of
accessibility to or post translational modifications of
other residues, thereby enhancing or masking the effect
of a given mutation on the accumulation of Cx32 in re-
sponse to HDAC6 inhibition. Additionally, it is possible
that HDAC6 inhibition causes Cx32 accumulation
through mechanisms that are both directly dependent
upon Cx32 acetylation and dependent upon the hypera-
cetylation of other HDAC6 substrates. However, since
we have shown that mutations that mimic constitutive
acetylation of C terminal lysines (K➔Q) recapitulate the
impact of HDAC6 inhibition on Cx32 turnover, ubiquiti-
nation and plasma membrane localization, the accumu-
lation of Cx32 that is observed after HDAC6 inhibition
can be largely attributed to direct modulation of
post-translational modifications of Cx32.
Expression levels of 5R Cx32 acetylation were roughly
equivalent to WT but did not increase in response to
HDAC6 inhibition. This suggests that the five
C-terminal lysines are acetylated in response to HDAC6
inhibition, and that other acetylated Cx32 lysine targets
remain in the full-length protein. A possible source of
this residual acetylation in the 5R mutant may be the re-
sult of additional or spurious acetylation of other lysines
when normal sites are unavailable. 5Q Cx32 acetylation
is visibly decreased as compared to 5R and WT, suggest-
ing that the K➔Q mutation specifically succeeds in elim-
inating acetylation sites. Total acetylation levels of 5Q
Cx32 increase after HDAC6 inhibition, with no con-
comitant increase in Cx32 protein accumulation.
We detected Cx32 as a doublet by Western blotting
when cells expressing WT or TubA sensitive mutants
were treated with TubA or when putative acetylation sites
were mutated to glutamine (5Q) to mimic constitutive
acetylation. It is possible that the higher molecular mass
band in these samples is an additional post translationally
modified form of Cx32. A previous study identified S240
as a phosphorylation site and C280/283 as palmitoylation
sites [45]. Given the proximity of those residues to the pu-
tative acetylation sites identified here, it is conceivable that
those or other post translational modifications could be
positively regulated by acetylation.
Acetylation of Cx32 also appears to alter proliferation
of transfected N2a cells. Specifically, expression of 5R,
which blocks acetylation and conserves the charge prop-
erties of the mutated lysines, reduced proliferation, while
proliferation in cells expressing the acetylation mimetic,
5Q, did not differ significantly from those expressing
A B
C
Fig. 6 C-terminal lysine mutants form functional gap junctions. a Dual whole-cell recordings showed no significant differences in junctional
conductance (Gj) between WT, 5R, or 5Q cell pairs. Mean Junctional conductances for pIRES2EGFP (I), WT, 5R, and 5Q Cx32 are plotted. b Cells in
experiments plotted here were transfected with 3-fold more DNA than in A; no influence on Gj activity is observed. c Representative average
normalized Gj-Vj relations with 5R (left) and 5Q (right) are compared with Cx32WT channels. The average normalized instantaneous (open triangles)
and steady-state (filled squares) junctional conductance (Gj) at each Vj were calculated from current traces and fit as described in the Materials and
Methods. Solid lines represent fits to Cx32-5R or Cx32-5Q; broken lines represent fits to data for Cx32WT homotypic cell-cell channels
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WT. Expression of Cx32 can act as either a positive or a
negative regulator of proliferation depending upon the cell
type and physiological context [6]. Our results suggest that
acetylation of Cx32 is a modulator of proliferation and
that the loss of acetylation sites suppresses proliferation of
N2a cells. Thus, the acetylation state of C-terminal lysines
in Cx32 has a role in regulating proliferation, an essential
cell function. This modulation of proliferation rate may be
occurring through acetylation specific protein-protein in-
teractions rather than the general presence of lysines at
the positions that we analyzed. Simply substituting a lysine
with an amino acid that could not be otherwise modified
(Cx32 5Q versus Cx32 5R), for example by ubiquitination,
was not sufficient to suppress the proliferation modulating
function of Cx32. Additionally, stabilization of Cx32 alone
was not sufficient to modulate cellular proliferation be-
cause both 5Q and 5R Cx32 were more stable than WT
and accumulated in the cell, but only Cx32 5R suppressed
proliferation.
A recent study has identified several di-leucine-like
motifs in the C terminus of Cx32 that regulate its
endocytosis [67]. Two of our putative acetylation sites,
K250 and K260, fall within two of these dileucine like
motifs. Mutations within these motifs (L251A + L252A
and L263A + R264A) increase GJ surface area and slow
down turnover of Cx32 from the cell surface, due to re-
duced endocytosis. It is possible that cross talk between
post translational modifications such as acetylation and
ubiquitination involve these regulatory motifs.
Connexins are paradigmatic of a large cohort of pro-
teins that are regulated by interactions with binding
partners, which cause a particular sequence to change
from an intrinsically disordered state into a functional
secondary structure [68, 69]. For example, Stauch, et al.
[69] report that binding of calmodulin (CaM) to the
Cx32 C-terminus orders and stabilizes it into an
alpha-helix. Chemical gating of Cx32 GJ occurs in the
presence of high concentrations of Ca2+, which may
lead to CaM activation and structural change in the
C-terminus of Cx32 [43, 70]. Inhibition of CaM binding
or truncation of CaM binding sites resulted in cytoplas-
mic accumulation of Cx32, further highlighting the
A B
C
Fig. 7 Cellular proliferation is regulated by Cx32 acetylation. BrdU incorporation by N2a cells expressing the pCx32-IRESEGFP WT, 5R, or 5Q constructs
were quantified by immunofluorescent staining for Cx32 and BrdU, as described in methods. Following overnight incubation with medium containing
BrdU, cells were fixed, labeled and scored for Cx32 expression and BrdU incorporation. The percentage of BrdU-positive and Cx32 co-expressing cells
were normalized to the total number of Cx32-expressing cells for each construct. a The percentage of BrdU positive cells in 5R samples were
significantly reduced compared to WT (*p < 0.0026). b No differences in the percentage of Cx32 positive cells per total DAPI positive nuclei
(cell number) were noted. For each construct, three to four fields were imaged and quantified for each replicate coverslip per experiment using the
MultiWavelength Cell Scoring app in Metamorph, as described in the Methods. (N = 3 experiments for each construct). c Representative images of
BrdU incorporation by N2a cells expressing the pCx32-IRESEGFP WT, 5R, or 5Q constructs, labeled and processed as described above
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regulatory role of interactions between Cx32 C- terminus
and binding partners [66]. Other physiologically signifi-
cant roles, such as the regulation of GJ assembly [64], cel-
lular proliferation [44] and CO2 mediated GJ gating [71]
have also been identified for the C-terminus of Cx32.
However, little is known about the molecular mechanisms
that control these functions, potentially through
fine-tuning interactions between Cx32 and its binding
partners. The results presented here suggest that the pres-
ence or absence of an acetyl group or the charged lysine
in the C- terminus of Cx32 could be a modulator of inter-
actions with binding partners, leading to alterations in
Cx32 protein stability and physiological function.
Conclusions
We have identified acetylation sites in the five lysines in
the C-terminus of Cx32. Mutational analysis to acetyl-
ation deficient- or mimetic-residues demonstrates that
these lysines play a potential role in regulating Cx32 ubi-
quitination, stability, and turnover. Inhibition of HDAC6
leads to accumulation of acetylated Cx32 protein, pro-
viding further evidence for HDAC6 modulation of Cx32
acetylation levels. Further analysis of the C-terminal mu-
tants demonstrated that these critical lysine residues do
not alter Cx32-mediated gap junction conductances, ra-
ther the acetylation state of these C-terminal lysines ap-
pears to regulate Cx32 protein turnover and to impact
channel-independent functions, including cellular prolif-
eration. These results highlight the role of lysines in the
C-terminal tail of Cx32 in the fine-tuning of Cx32 stabil-
ity and channel-independent functions.
Additional files
Additional file 1: Figure S2. C-terminal lysines influence Cx32 localization
and HDACi response. (A.) Cell surface biotinylation was performed in order
to confirm the presence of WT, 5R, and 5Q Cx32 at the cell surface.
Biotinylated and total Cx32 were detected by probing Western blots with
an antibody against the Myc-tag. (B. and C.) N2A cells were transfected with
WT, 5R, or 5Q and treated with TubA or vehicle (C), as described in methods.
The amount of Cx32 at points of cellcell contact was measured by
quantifying the fluorescence intensity of Cx32 antibody staining 48 h
after transfection. (B.) Confocal images of Cx32 immunostaining, scale
bars are 25 μm and arrows indicate points of cell-cell contact.(C.) Anti-Cx32
fluorescence intensity at points of cellcell contact was measured. Average
fluorescence intensities at cell-cell contacts for each set of images is plotted.
(n = 15 cell pairs for each group; *p < 0.05 compared to WT -TubA, Student’s
T-test). (PDF 147 kb)
Additional file 2: Figure S3. C-terminal lysines influence Cx32 localization
and HDACi response. Additional representative images of WT Cx32 express-
ing N2a cells (+/- TubA) shown in Figure S2. (PDF 244 kb)
Additional file 3: Figure S4. C-terminal lysines influence Cx32 localization
and HDACi response. Additional representative images of 5R Cx32 expressing
N2a cells (+/- TubA) shown in Figure S2. (PDF 317 kb)
Additional file 4: Figure S5. C-terminal lysines influence Cx32 localization
and HDACi response. Additional representative images of 5Q Cx32 express-
ing N2a cells (+/- TubA) shown in Figure S2. (PDF 269 kb)
Additional file 5: Figure S1. Mutation of K231 and K260 does not
eliminate acetylation. N2a cells were transfected with pIRESeGFP-Cx32 WT
or K231+260R for 48 hours as described in methods section, then treated
overnight with 20 μM Tubastatin. Cx32 was immunoprecipitated and
blotted with indicated antibodies. (PDF 9 kb)
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